These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16640742)

  • 1. Cost-effectiveness of current and optimal treatment for adult asthma.
    Simonella L; Marks G; Sanderson K; Andrews G
    Intern Med J; 2006 Apr; 36(4):244-50. PubMed ID: 16640742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based medicine is affordable: the cost-effectiveness of current compared with optimal treatment in rheumatoid and osteoarthritis.
    Andrews G; Simonella L; Lapsley H; Sanderson K; March L
    J Rheumatol; 2006 Apr; 33(4):671-80. PubMed ID: 16541479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of major depression avoidable by longer-term treatment strategies.
    Vos T; Haby MM; Barendregt JJ; Kruijshaar M; Corry J; Andrews G
    Arch Gen Psychiatry; 2004 Nov; 61(11):1097-103. PubMed ID: 15520357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD; Turk F
    Allergy; 2008 Jun; 63(6):670-84. PubMed ID: 18445184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma.
    Brown R; Turk F; Dale P; Bousquet J
    Allergy; 2007 Feb; 62(2):149-53. PubMed ID: 17298423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders.
    Issakidis C; Sanderson K; Corry J; Andrews G; Lapsley H
    Psychol Med; 2004 Jan; 34(1):19-35. PubMed ID: 14971624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
    Chisholm D;
    Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
    Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
    Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of asthma clinic approach in the management of chronic asthma in Australia.
    Mogasale V; Vos T
    Aust N Z J Public Health; 2013 Jun; 37(3):205-10. PubMed ID: 23731101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-of-illness of asthma in Denmark in the year 2000].
    Mossing R; Nielsen GD
    Ugeskr Laeger; 2003 Jun; 165(26):2646-9. PubMed ID: 12886546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: a simulation study.
    Zafari Z; Lynd LD; FitzGerald JM; Sadatsafavi M
    J Allergy Clin Immunol; 2014 Oct; 134(4):908-915.e3. PubMed ID: 24875619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of two self-care interventions to reduce disability associated with back pain.
    Strong LL; Von Korff M; Saunders K; Moore JE
    Spine (Phila Pa 1976); 2006 Jul; 31(15):1639-45. PubMed ID: 16816756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
    Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacoeconomics of asthma].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
    Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
    Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of asthma treatment with a breath-actuated inhaler: how has the story changed?
    Haycox A; Featherstone R
    J Med Econ; 2008; 11(3):525-39. PubMed ID: 19450102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of current and optimal treatment for schizophrenia.
    Andrews G; Sanderson K; Corry J; Issakidis C; Lapsley H
    Br J Psychiatry; 2003 Nov; 183():427-35; discussion 436. PubMed ID: 14594918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
    Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
    Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.